India begins a nationwide vaccine drive using the Oxford-AstraZeneca shot and the indigenous "Covaxin" by Bharat Biotech. The latter has raised alarm bells for being approved before clinical trials were concluded. The hosts question why India's death numbers are so low compared to the U.S. despite its much larger population.
